ICD-10 Coding for Hepatoma(C22.0)
Complete ICD-10-CM coding and documentation guide for Hepatoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Hepatoma
C22.0-C22.9Primary Range
Malignant neoplasms of liver and intrahepatic bile ducts
This range includes codes for primary liver cancers, including hepatocellular carcinoma and other specified liver malignancies.
Key Information: ICD-10 code for hepatoma
Essential facts and insights about Hepatoma
Primary ICD-10-CM Code for hepatoma
Decision Criteria
clinical Criteria
- Presence of arterial phase hyperenhancement on imaging
documentation Criteria
- Explicit mention of 'hepatocellular carcinoma' or 'hepatoma'
Applicable To
- Hepatoma
- Hepatocellular carcinoma
Excludes
- C22.1 (Intrahepatic bile duct carcinoma)
Clinical Validation Requirements
- Histologic confirmation via biopsy
- Imaging showing arterial phase hyperenhancement with washout
- AFP levels >200 ng/mL
Code-Specific Risks
- Misuse when documentation is insufficiently specific
- Failure to document underlying liver disease
Coding Notes
- Ensure documentation specifies 'hepatocellular carcinoma' to avoid miscoding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Hepatoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C22.0.
Impact
Clinical: Incomplete clinical picture affecting treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Reduced reimbursement due to incorrect DRG.
Mitigation Strategy
Always document cirrhosis or hepatitis if present.
Impact
Reimbursement: Potential decrease in reimbursement due to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation Strategy
Ensure documentation specifies 'hepatocellular carcinoma' or 'hepatoma'.
Impact
High audit risk if HCC is coded without imaging or histologic confirmation.
Mitigation Strategy
Ensure all HCC diagnoses are supported by appropriate clinical evidence.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Hepatoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Hepatoma
Use these documentation templates to ensure complete and accurate documentation for Hepatoma. These templates include all required elements for proper coding and billing.
HCC with cirrhosis and hepatitis C
Specialty: GastroenterologyRequired Elements
- Diagnosis of hepatocellular carcinoma
- Underlying liver disease (e.g., cirrhosis)
- Etiology (e.g., hepatitis C)
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Hepatoma? Ask your questions below.